{"id":"https://openalex.org/W3083178592","doi":"https://doi.org/10.1158/1538-7445.am2020-6055","title":"Abstract 6055: Discovery of epitope-selective anti-CD25 targeting therapeutic antibodies for effective Treg cell depletion in cancer using a novel AI/ML based platform","display_name":"Abstract 6055: Discovery of epitope-selective anti-CD25 targeting therapeutic antibodies for effective Treg cell depletion in cancer using a novel AI/ML based platform","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083178592","doi":"https://doi.org/10.1158/1538-7445.am2020-6055","mag":"3083178592"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-6055","doi":"https://doi.org/10.1158/1538-7445.am2020-6055","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6055","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058082861","display_name":"Phung Gip","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phung Gip","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100339896","display_name":"Bing Li","orcid":"https://orcid.org/0000-0001-6983-7253","observed_orcids":["https://orcid.org/0000-0001-6983-7253"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bing Li","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077151236","display_name":"Angeles Estell\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angeles Estelles","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045448373","display_name":"Hanako Daino-Laizure","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanako Daino-Laizure","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022412660","display_name":"Oleg Gurinovich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oleg Gurinovich","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079251312","display_name":"Piotr Zalicki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piotr Zalicki","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033805877","display_name":"Kevin Hauser","orcid":"https://orcid.org/0000-0002-4579-4794","observed_orcids":["https://orcid.org/0000-0002-4579-4794"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Hauser","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089740436","display_name":"Alex Taguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Taguchi","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082405466","display_name":"Christian L. Barrett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Barrett","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071780539","display_name":"Andrew Morin","orcid":"https://orcid.org/0000-0001-5470-946X","observed_orcids":["https://orcid.org/0000-0001-5470-946X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Morin","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019038548","display_name":"Jordan R. Willis","orcid":"https://orcid.org/0000-0002-0135-5263","observed_orcids":["https://orcid.org/0000-0002-0135-5263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordan Willis","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mohan Srinivasan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohan Srinivasan","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010492218","display_name":"Isaac Bright","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isaac Bright","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012857655","display_name":"Matthew P. Greving","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Greving","raw_affiliation_strings":["RubrYc Therapeutics, San Carlos, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RubrYc Therapeutics, San Carlos, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"6055","last_page":"6055"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.026900000870227814,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-cd25-antibody","display_name":"anti-CD25 antibody","score":0.9150000214576721},{"id":"https://openalex.org/keywords/treg-depletion","display_name":"Treg depletion","score":0.871999979019165},{"id":"https://openalex.org/keywords/immunodominance","display_name":"immunodominance","score":0.7070000171661377},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.878000020980835},{"id":"https://openalex.org/keywords/il-2-signaling","display_name":"IL-2 signaling","score":0.7950000166893005},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.7760000228881836},{"id":"https://openalex.org/keywords/human-igg1","display_name":"human IgG1","score":0.527999997138977},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.9551515579223633},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6352812051773071},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5245433449745178},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4876231253147125},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.4432862102985382},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.43394890427589417},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38650473952293396},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36658376455307007},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3570248484611511},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23066410422325134}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-6055","doi":"https://doi.org/10.1158/1538-7445.am2020-6055","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6055","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2886355829","https://openalex.org/W4414534182","https://openalex.org/W2086590763","https://openalex.org/W4404052978","https://openalex.org/W2912427403","https://openalex.org/W4362545194","https://openalex.org/W2887327765","https://openalex.org/W3082505282","https://openalex.org/W4282964417","https://openalex.org/W4390615711"],"abstract_inverted_index":{"Abstract":[0],"Therapeutic":[1],"antibodies":[2,164,209,294],"have":[3],"contributed":[4],"significantly":[5],"to":[6,63,68,89,177,196,212,231],"better":[7],"clinical":[8,19],"outcomes":[9],"across":[10],"multiple":[11],"tumor":[12,29],"types.":[13],"However,":[14],"there":[15],"is":[16,39,97],"still":[17],"unmet":[18],"need":[20],"in":[21,35,86,107,120,153,201,202,300],"cancers":[22],"with":[23,131,251],"an":[24,42],"immunosuppressive":[25],"and":[26,60,175,184,190,199,221,241,254,326],"stroma":[27],"rich":[28],"microenvironment":[30],"(TME).":[31],"One":[32],"key":[33],"limitation":[34],"early":[36],"antibody":[37,50,64,87,136,246],"discovery":[38,65,137,247],"immunodominance":[40],"-":[41],"evolutionary":[43],"bias":[44],"toward":[45,92],"specific":[46],"epitopes":[47,147,172],"that":[48,104,142,237],"steer":[49,90],"selection":[51,88],"away":[52],"from":[53,165],"potentially":[54],"high-efficacy":[55],"epitopes.":[56,75,94],"Our":[57],"integrated":[58,239],"computational":[59,240],"laboratory":[61,242],"approach":[62],"enabled":[66],"us":[67],"build":[69],"focused":[70],"epitope":[71,77,180],"embodiments":[72],"of":[73,111,167,289,311,315],"structural":[74,146],"These":[76,234],"embodiments,":[78],"called":[79],"Meso-scale":[80],"Engineered":[81],"Molecules":[82],"(MEMs),":[83],"are":[84],"used":[85],"hits":[91],"intended":[93,170],"CD25":[95,145,171],"(IL2R\u03b1)":[96],"highly":[98],"expressed":[99],"on":[100,179],"regulatory":[101],"T-cells":[102],"(Tregs)":[103],"drive":[105],"immunosuppression":[106],"the":[108,121,125,149,168,245,312,316],"TME.":[109],"Depletion":[110],"Tregs":[112],"can":[113],"restore":[114],"anti-tumor":[115],"T":[116],"effector":[117,228],"(Teff)":[118],"function":[119,253],"TME,":[122],"by":[123,181],"increasing":[124],"Teff/Treg":[126],"ratio,":[127],"especially":[128],"when":[129],"combined":[130],"checkpoint-inhibitors.":[132],"Using":[133],"our":[134,238],"epitope-selective":[135,191,290],"platform,":[138],"we":[139],"built":[140],"MEMs":[141],"embody":[143],"eight":[144,169],"outside":[148],"CD25:IL-2":[150],"interface.":[151],"Through":[152],"vitro":[154,203],"selection,":[155],"several":[156],"high-affinity":[157],"(median":[158],"KD":[159],"=":[160],"25":[161],"nM)":[162],"anti-CD25":[163,192,291],"each":[166],"were":[173,194],"identified":[174],"confirmed":[176],"be":[178],"cross-blocking":[182],"assays":[183,220],"in-epitope":[185],"alanine":[186],"mutations.":[187],"Several":[188],"conventional-":[189],"clones":[193,250],"converted":[195],"human":[197,227],"IgG1":[198],"tested":[200],"assays.":[204],"As":[205],"a":[206,303],"result,":[207],"these":[208],"bound":[210],"specifically":[211],"CD25+":[213],"cells,":[214,229],"preserve":[215],"IL-2":[216],"signaling":[217],"via":[218],"pSTAT5":[219],"elicited":[222],"potent":[223],"ADCC":[224],"activity":[225],"using":[226,302],"superior":[230],"benchmark":[232],"antibodies.":[233],"studies":[235],"show":[236],"platform":[243,307],"improves":[244],"process,":[248],"producing":[249],"biological":[252],"improved":[255],"therapeutic":[256,293],"efficacy.":[257],"Citation":[258],"Format:":[259],"Phung":[260],"Gip,":[261],"Bing":[262],"Li,":[263],"Angeles":[264],"Estelles,":[265],"Hanako":[266],"Daino-Laizure,":[267],"Oleg":[268],"Gurinovich,":[269],"Piotr":[270],"Zalicki,":[271],"Kevin":[272],"Hauser,":[273],"Alex":[274],"Taguchi,":[275],"Christian":[276],"Barrett,":[277],"Andrew":[278],"Morin,":[279],"Jordan":[280],"Willis,":[281],"Mohan":[282],"Srinivasan,":[283],"Isaac":[284],"Bright,":[285],"Matt":[286],"Greving.":[287],"Discovery":[288],"targeting":[292],"for":[295,319],"effective":[296],"Treg":[297],"cell":[298],"depletion":[299],"cancer":[301],"novel":[304],"AI/ML":[305],"based":[306],"[abstract].":[308],"In:":[309],"Proceedings":[310],"Annual":[313],"Meeting":[314],"American":[317],"Association":[318],"Cancer":[320,332],"Research":[321],"2020;":[322],"2020":[323],"Apr":[324],"27-28":[325],"Jun":[327],"22-24.":[328],"Philadelphia":[329],"(PA):":[330],"AACR;":[331],"Res":[333],"2020;80(16":[334],"Suppl):Abstract":[335],"nr":[336],"6055.":[337]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2020-09-11T00:00:00"}